Report
FDA accepts Zydus' application for a Keytruda biosimilar
The Economic Times reports that the acceptance moves Zydus closer to the US market for the biosimilar.
TLDR
The FDA has accepted Zydus' application for a Keytruda biosimilar, bringing the company closer to the US market, The Economic Times reports.
Combined views
—
1 Source, first seen ago
— likes— comments— saves— reposts